The new version of ‘Quality Solutions for Inhaler Testing'
from Copley Scientific not only showcases the latest developments in inhaled
product testing equipment but also provides
practical guidance on achieving robust and reliable measurement and
analysis. 
A ‘go to' resource for expert advice that is rooted in the latest
regulatory guidance and pharmacopoeial monographs, the new brochure includes
details of a cluster of novel products designed to deliver better in vitro in
vivo relationships (IVIVRs) for all orally inhaled and nasal drug products
(OINDPs).
Beginning with a review of the role of different
organisations, expert groups and regulatory authorities, ‘Quality Solutions for
Inhaler Testing' presents the Copley range of inhaled product testing equipment
within the context of how it can be used to meet research, development and QC
requirements. The new edition has been comprehensively revised, most noticeably
to reflect an increased focus on achieving better IVIVRs. This is perceived by
leading researchers as being critical for more effective inhaled product
development.
Since the last edition of the brochure (2010), Copley have
introduced a number of new tools for more representative testing, including:
the Alberta Idealised Throat; breathing simulators for the testing of
nebulisers and inhalers; and extensions to the abbreviated impactor measurement
(AIM) range, which aids faster analysis. Other important innovations include
the new Plume Temperature tester, which is used in the assessment of the ‘Cold
Freon' effect, induced by propellant driven inhalers, and a new super capacity
vacuum pump, specified for use at the highest test flow rates when testing DPI.
To find out more, download the brochure at
www.copleyscientific.com or request
your free copy by sending an email to
sales@copleyscientific.co.uk
